Author:
Li Lu,Yang Yue,Li Wang,Zhao Xian,He Jia,Mei Shuo,Guo Xuejun,Zhang Xibin,Ran Jianghua
Abstract
Abstract
Objective
To describe the clinical outcome and physical condition of patients with locally advanced breast cancer (LABC) who received neoadjuvant chemotherapy followed by mastectomy and latissimus dorsi myocutaneous flap repair.
Methods
A retrospective review of 142 patients with locally advanced breast cancer was selected from 1156 breast cancer patients in the South and North areas of The Affiliated Calmette Hospital of Kunming Medical University between May 2008 and December 2018.
Results
All participants (n = 142) were women aged 40–55 years (average age 47.35 ± 0.43 years) who received neoadjuvant chemotherapy followed by mastectomy and latissimus dorsi flap repair. The median follow-up period was 16 months (range 12–24 months). For stage of disease, there were 19 cases (13%) in stage IIB, 31 cases (22%) in stage IIIA, 39 cases (28%) in stage IIIB, and 53 cases (37%) in stage IIIC, which were statistically significant with the physical condition of patients (≤ 0.001). Neoadjuvant chemotherapy was administered to shrink the tumors, and an average tumor size decrease from 10.05 ± 1.59 cm × (8.07 ± 1.54) cm to 6.11 ± 1.72 cm × (3.91 ± 1.52) cm (P < 0.001) was considered statistically significant. A t test was used for the ECOG score statistics, and the results showed that the scores were statistically significant (≤ 0.001) before and after neoadjuvant chemotherapy and after surgery.
Conclusions
Neoadjuvant chemotherapy is an accepted treatment option for patients with locally advanced breast cancer, and the use of a latissimus dorsi musculocutaneous flap for post-mastectomy reconstruction may improve the patients’ physical condition. Our results indicated that this strategy was safe and feasible.
Funder
National Natural Science Foundation of China
Yunnan Science and Technology Department and the Kunming Medical University Applied Basic Research Joint Special Fund
Kunming science and technology planning project
Publisher
Springer Science and Business Media LLC
Reference40 articles.
1. Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2015;68:394–424. https://doi.org/10.3322/caac.21492.
2. Bellanger M, Zeinomar N, Tehranifar P, Terry MB. Are global breast cancer incidence and mortality patterns related to country-specific economic development and prevention strategies? J Glob Oncol. 2018;4:1–16. https://doi.org/10.1200/JGO.17.00207.
3. Li Y, Xi Y, Liu Q, Zhang N, Nie J. Baseline characteristics of breast cancer in Yunnan Province, China. Mod Onco. 2014;22:64.
4. NCCN Clinical Practice Guidelines Oncology. Breast Cancer. 2019. https://www.nccn.org/professionals/physician_gls/default.aspx
5. Bertozzi N, Pesce M, Santi P, Raposio E. One-stage immediate breast reconstruction: a concise review. Biomed Res Int. 2017;2017:6486859. https://doi.org/10.1155/2017/6486859.
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献